Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells

Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Weidong Li, Xuesong Dong, Changjun He, Gang Tan, Ziyi Li, Bo Zhai, Jing Feng, Xian Jiang, Chang Liu, Hongchi Jiang, Xueying Sun
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/7e738de5753f4c2aa531bec93f96d5a7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
id oai:doaj.org-article:7e738de5753f4c2aa531bec93f96d5a7
record_format dspace
spelling oai:doaj.org-article:7e738de5753f4c2aa531bec93f96d5a72021-12-05T12:10:08ZCorrection to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells10.1186/s13046-021-02183-31756-9966https://doaj.org/article/7e738de5753f4c2aa531bec93f96d5a72021-12-01T00:00:00Zhttps://doi.org/10.1186/s13046-021-02183-3https://doaj.org/toc/1756-9966Weidong LiXuesong DongChangjun HeGang TanZiyi LiBo ZhaiJing FengXian JiangChang LiuHongchi JiangXueying SunBMCarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-3 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Weidong Li
Xuesong Dong
Changjun He
Gang Tan
Ziyi Li
Bo Zhai
Jing Feng
Xian Jiang
Chang Liu
Hongchi Jiang
Xueying Sun
Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
format article
author Weidong Li
Xuesong Dong
Changjun He
Gang Tan
Ziyi Li
Bo Zhai
Jing Feng
Xian Jiang
Chang Liu
Hongchi Jiang
Xueying Sun
author_facet Weidong Li
Xuesong Dong
Changjun He
Gang Tan
Ziyi Li
Bo Zhai
Jing Feng
Xian Jiang
Chang Liu
Hongchi Jiang
Xueying Sun
author_sort Weidong Li
title Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
title_short Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
title_full Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
title_fullStr Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
title_full_unstemmed Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
title_sort correction to: lncrna snhg1 contributes to sorafenib resistance by activating the akt pathway and is positively regulated by mir-21 in hepatocellular carcinoma cells
publisher BMC
publishDate 2021
url https://doaj.org/article/7e738de5753f4c2aa531bec93f96d5a7
work_keys_str_mv AT weidongli correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
AT xuesongdong correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
AT changjunhe correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
AT gangtan correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
AT ziyili correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
AT bozhai correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
AT jingfeng correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
AT xianjiang correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
AT changliu correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
AT hongchijiang correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
AT xueyingsun correctiontolncrnasnhg1contributestosorafenibresistancebyactivatingtheaktpathwayandispositivelyregulatedbymir21inhepatocellularcarcinomacells
_version_ 1718372201637347328

Documents similaires